5/24/2021
The FDIC, NCUA, and OCC have extended the comment period for their Request for Information on Financial Institutions' Use of Artificial Intelligence, including Machine Learning, from March 31, 2021, to July 1, 2021, due to concerns about the complexity of the topic and the need for adequate time to analyze and respond to the request.
5/21/2021
The U.S. Nuclear Regulatory Commission (NRC) is seeking public input on its draft Interim Staff Guidance (ISG) that proposes changes to the review process for license amendment requests related to boiling water reactors, specifically regarding the main steam isolation valve leakage allowed by technical specifications.
5/21/2021
The US Department of Agriculture is proposing changes to import regulations for fresh melon fruit from Japan, aiming to address pest risks associated with importing fruit with stems, and to expand import access to the continental US and more territories.
5/21/2021
The Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA) is proposing to add a new system of records, entitled USDA/APHIS-23, Integrated Plant Health Information System (IPHIS), to maintain records of activities related to plant health and bee conservation.
5/21/2021
The US Department of Agriculture is distributing non-competitive grant funding for technology innovation in Child Nutrition Programs, starting from fiscal year 2021, and invites comments on this approach, replacing the competitive CN Technology Innovation Grants previously administered by the Food and Nutrition Service.
5/21/2021
The Farm Credit Administration (FCA) has issued a direct final rule to repeal certain regulations related to conservatorship and receivership, effective 30 days after publication in the Federal Register. This repeal is in line with the Agricultural Improvement Act of 2018.
5/21/2021
The General Services Administration (GSA) is hosting an IPv6 Summit to bring together federal and industry experts to discuss the implementation of Internet Protocol Version 6 (IPv6) in the federal government, covering progress, opportunities, and best practices.
5/21/2021
The U.S. International Trade Commission has decided to review part of a recent ruling on a mobile device investigation, finding no evidence of a violation of Section 337. The Commission is seeking written submissions from parties on issues related to remedy, public interest, and bonding.
5/21/2021
The US Commission will review the countervailing duty orders on uncoated paper from China and Indonesia, and the antidumping duty orders on uncoated paper from Australia, Brazil, China, Indonesia, and Portugal to determine if revoking these duties would harm US producers
5/21/2021
The U.S. International Trade Commission has decided not to review two initial determinations related to a complaint against certain companies, including Lowe's and O'Reilly, regarding portable battery jump starters and components. The investigation has been terminated for these companies due to settlement agreements.
5/21/2021
The Food and Drug Administration is seeking public input on its proposed collection of information related to the labeling of certain beers, as required by the Paperwork Reduction Act of 1995, and invites comments within 60 days.
5/21/2021
The Food and Drug Administration (FDA) has announced the availability of a final guidance on its policy regarding the use of National Health Related Item Code (NHRIC) and National Drug Code (NDC) numbers on device labels and packages, allowing for the continued use of FDA legacy identification numbers for finished devices manufactured before September 24, 2023.
5/21/2021
The FDA has announced the availability of a final guidance for industry on how to demonstrate bioequivalence for soluble powder oral dosage form products and Type A medicated articles containing active pharmaceutical ingredients that dissolve in water
5/21/2021
The Food and Drug Administration (FDA) has published a draft guidance outlining its recommendations for adjusting for covariates in randomized clinical trials for drugs and biologics, which is expected to be finalized and replace its previous 2019 guidance
5/21/2021
The Food and Drug Administration (FDA) is hosting a public meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to gather input on regulatory issues. The meeting will be open to the public, and the FDA is seeking public comments on the proposed agenda.
5/21/2021
The Federal Housing Finance Agency is requesting public comments on an information collection related to Federal Home Loan Bank Directors, which is set to expire on February 28, 2021, and is seeking a three-year extension
5/21/2021
The Bureau of Consumer Financial Protection is requesting a revision to an existing information collection, titled 'Report of Terms of Credit Card Plans (Form FR 2572) and Consumer and College Credit Card Agreements,' in accordance with the Paperwork Reduction Act of 1995. This revision aims to update the form to better align with changing consumer financial regulations.
5/21/2021
The State Small Business Credit Initiative (SSBCI) invites public comment on its program design and implementation to support small businesses affected by the COVID-19 pandemic, with Treasury allocating up to $10 billion in funding.
5/21/2021
The Department of Justice is proposing changes to Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF) regulations to clarify definitions of key terms related to firearms, including 'firearm frame or receiver' and 'gunsmith', in response to advancements in firearms technology.
5/21/2021
The U.S. government has released a final environmental impact statement for a proposed development of a federal correctional institution and federal prison camp on the grounds of the United States Penitentiary in Leavenworth, Kansas, following a record of decision.
5/21/2021
The Department of Justice, through the Federal Bureau of Investigation's Criminal Justice Information Services Division, is seeking approval from the Office of Management and Budget for a pilot testing program to collect law enforcement suicide data, as required by the Paperwork Reduction Act of 1995.
5/21/2021
The Department of Labor is seeking public comment on an Occupational Safety and Health Administration-sponsored information collection request, which must be reviewed and approved by the Office of Management and Budget under the Paperwork Reduction Act of 1995.
5/21/2021
The Federal Emergency Management Agency (FEMA) has amended its previous declaration of a major disaster for Public Assistance Only in Washington State, which was initially issued on April 8, 2021, in response to a severe winter storm that caused widespread damage, including straight-line winds, flooding, landslides, and mudslides, from December 29, 2020, through January 16, 2021.
5/21/2021
The Federal Deposit Insurance Corporation (FDIC) is seeking public comment on the renewal of existing information collections, as required by the Paperwork Reduction Act of 1995, and invites other Federal agencies to participate in the process.
5/21/2021
The Federal Deposit Insurance Corporation (FDIC) is requesting information and comments from interested parties on the use of digital assets by insured depository institutions and their affiliates.
5/21/2021
The Office of the Comptroller of the Currency (OCC) is seeking public comment on the renewal of its information collection, 'Credit Risk Retention,' as part of its efforts to reduce paperwork burden. The OCC has submitted the collection to the Office of Management and Budget (OMB) for review, in accordance with the Paperwork Reduction Act of 1995 (PRA).
5/21/2021
The Federal Reserve Board has issued an interim final rule to extend the exception for certain loans made through March 31, 2022, that are guaranteed under the Small Business Administration's Paycheck Protection Program, allowing these loans to be exempt from the Federal Reserve Act and Regulation O requirements.
5/20/2021
The U.S. Nuclear Regulatory Commission is publishing a final Environmental Assessment and a Finding of No Significant Impact for its review and approval of decommissioning funding plans submitted by independent spent fuel storage installation licensees.
5/20/2021
The U.S. Nuclear Regulatory Commission has issued a final Environmental Assessment and a Finding of No Significant Impact for its review and approval of decommissioning funding plans submitted by independent spent fuel storage installation licensees, clearing the way for the decommissioning of these facilities.
5/20/2021
CTIA has submitted petitions for reconsideration of the Commission's recent action in its rulemaking proceeding, led by Thomas C. Power on behalf of the Cellular Telecommunications and Internet Association.
5/20/2021
The Federal Communications Commission is holding its first meeting of the Ending 9-1-1 Fee Diversion Now Strike Force, a committee established to address 9-1-1 fee diversion issues, as mandated by the Federal Advisory Committee Act.
5/20/2021
USTelecom--The Broadband Association has submitted a petition for reconsideration of a recent FCC rulemaking decision, filed by Joshua M. Bercu on their behalf, in an effort to challenge the outcome of the proceeding.
5/20/2021
The Federal Communications Commission is revising its electronic filing rules for licenses in the Wireless Radio Services after discovering a modification to the rule was made before the scheduled implementation date.
5/20/2021
The Rural Business-Cooperative Service is accepting applications for the Delta Health Care Services grant program, which provides $3 million in funding for projects in persistent poverty counties in the Delta Region. The program aims to address unmet health needs through collaboration among healthcare professionals, institutions, and economic development entities.
5/20/2021
The US Department of Agriculture's Rural-Business Cooperative Service is allocating $2 million in reserved funds to support economic development projects in rural coastal areas affected by wildfires, with a focus on innovation and job creation.
5/20/2021
The Farm Credit Administration is proposing changes to its regulations on appraisal and evaluation requirements for properties used as collateral for loans made by the Farm Credit System, aiming to clarify valuation standards and introduce new requirements for automated valuation tools.
5/20/2021
The Office of Management and Budget (OMB) is reviewing a proposal by a federal agency to collect data for the 2020 Public Use Microdata Areas Program, and the agency is seeking public comment on the submission.
5/20/2021
The U.S. International Trade Commission has permanently rescinded a limited exclusion order and cease and desist order related to road construction machines and components, effectively terminating a rescission proceeding
5/20/2021
The US Commission has announced it will conduct a full five-year review of the antidumping duty order on potassium permanganate imports from China to determine if revoking the order would harm US producers, and will set a schedule for the review at a later date.
5/20/2021
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on March 5, 2021, regarding the withdrawal of approval for seven abbreviated new drug applications (ANDAs) from multiple applicants, including Neopharma, Inc., as of April 5, 2021. The FDA had withdrawn approval for five ANDAs after receiving a withdrawal request from Neopharma, Inc., but later reinstated approval for five of the ANDAs after Neopharma, Inc. timely requested that the approval not be withdrawn.
5/20/2021
The Food and Drug Administration (FDA) has made additional draft and revised draft product-specific guidances available, providing recommendations on bioequivalence studies to support abbreviated new drug applications (ANDAs). These guidances were developed using the process outlined in the FDA's June 11, 2010, guidance for industry, 'Bioequivalence Recommendations for Specific Products'.
5/20/2021
The Food and Drug Administration (FDA) has released a final guidance document outlining updated recommendations for submitting premarket notifications for new or modified peripheral vascular atherectomy devices, a type of medical device used to treat peripheral artery disease.
5/20/2021
The FDA has determined that AVACLYR, a 3% acyclovir ointment, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications
5/20/2021
The US Food and Drug Administration (FDA) has ruled that NORMODYNE (labetalol hydrochloride) injection, 5 mg/mL, was not withdrawn from the market due to safety or efficacy concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) for the product.
5/20/2021
The Food and Drug Administration (FDA) has made available a final guidance document outlining the testing and labeling requirements for medical devices in the Magnetic Resonance (MR) environment, aiming to enhance consistency in reviews and safety labeling across various medical devices.
5/20/2021
The FDA has released a draft guidance outlining recommendations for clinical studies of medical devices aimed at improving glycemic control in Type 2 diabetes patients, without relying on insulin delivery.
5/20/2021
The FDA has released a final guidance for industry on abbreviated new drug applications for synthetic peptide drug products that refer to previously approved rDNA origin drugs, helping potential applicants determine when to submit an ANDA instead of a new drug application.
5/20/2021
The FDA has released a draft guidance for industry on implementing ICH Q12, a framework for managing postapproval changes in pharmaceutical products, to enhance transparency and efficiency in the regulatory process
5/20/2021
The Food and Drug Administration (FDA) has released a draft guidance document that partially revises its previous guidance on clinical trial investigators, explaining the agency's current thinking on waivers of the signature requirement for Form FDA 1572, a critical form used in clinical trials.
5/20/2021
The FDA is releasing a final guidance document outlining non-clinical testing and clinical considerations for implanted brain-computer interface devices intended for patients with paralysis or amputation, aiming to facilitate the development of these neuroprosthetic devices.